Ultralife Corporation Files Notification for Late Q3 Results
Ultralife Corporation (NASDAQ: ULBI) has officially filed a Form 12b-25 with the Securities and Exchange Commission, indicating a delay in submitting its Form 10-Q for the third quarter that concluded on September 30, 2025. This move comes in light of recent transitions within the company following its acquisition of Electrochem Solutions, Inc.
Understanding the Transition
On October 31, 2024, Ultralife completed the acquisition of Electrochem, previously held by Integer Holdings Corporation. Following this acquisition, a transition services agreement allowed Integer to manage Electrochem's records during a pivotal period. However, as the agreement has ended, Ultralife embarked on transferring Electrochem’s operational records to its own systems. The company recognized that this transition required additional time to ensure all financial matters were meticulously addressed.
Expected Filing Timeline
Due to the complexities of this transition and to allow for thorough reviews by their independent accountants, Ultralife disclosed that it needs extra time to finalize the Q3 results. The company anticipates that the Form 10-Q will be filed by November 17, 2025, in compliance with the stipulations of Rule 12b-25. This timeline reflects Ultralife’s commitment to precision in reporting, essential for maintaining trust with investors and stakeholders.
About Ultralife Corporation
Ultralife Corporation is a thriving player in the power solutions and communications systems sectors. With its head office located in Newark, New York, the company has carved a niche for itself by providing innovative products and services that cater to government, defense, and commercial markets worldwide. Their operational infrastructure spans across North America, Europe, and Asia, showcasing a robust international presence.
Company’s Core Focus
The company's business segments are divided into Battery & Energy Products and Communications Systems, allowing it to serve a variety of customer needs effectively. Ultralife's engineering and collaborative ethos in problem-solving sets it apart in the competitive marketplace. The focus on quality and customer satisfaction is paramount, evidenced by their dedicated customer service and product development teams.
Company Contact Information
For any inquiries, Ultralife Corporation can be reached directly. Below are the contact details for their corporate and investor relations teams:
Company Contact:
Ultralife Corporation
Philip A. Fain
Phone: (315) 210-6110
Email: pfain@ulbi.com
Investor Relations Contact:
Alliance Advisors IR
Jody Burfening/Alex Villalta
Phone: (212) 838-3777
Emails: jburfening@allianceadvisors.com, avillalta@allianceadvisors.com
Frequently Asked Questions
What is the reason for the late filing of the Q3 results?
The delay is primarily due to the requirements for transitioning Electrochem's records to Ultralife's systems, which necessitated additional time to finalize financial reports.
When does Ultralife expect to file its 10-Q?
Ultralife aims to submit its Form 10-Q by November 17, 2025, adhering to regulatory guidelines.
What are Ultralife’s main business segments?
The company operates primarily in Battery & Energy Products and Communications Systems, catering to diverse market needs.
How can I contact Ultralife Corporation?
Ultralife can be reached at their corporate contact number (315) 210-6110 or through the provided email addresses for inquiries.
Where is Ultralife Corporation located?
Ultralife Corporation is headquartered in Newark, New York, and has operations in North America, Europe, and Asia.
